Synendos Therapeutics Appoints Scientific Advisory Board
Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise. Read more
Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise. Read more
8-15 NOV 2021 | Hybrid
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
Arix Bioscience (ARIX) CEO Joe Anderson talked to VoxMarkets about investing in and building breakthrough biotech companies to market.
26-27 February, 2018 | Zurich, Switzerland